[PDF][PDF] The art of bone scintigraphy—technical aspects

…, ML Brown, JC Hung, RJ Hayostek - Journal of Nuclear …, 1991 - Soc Nuclear Med
@ â€,.@ provements in camera design and performance that have resulted in the availability
today of dedicated whole-body imaging systems and dedicated multihead tomographic …

Technical aspects of bone scintigraphy

…, MK O'Connor, JC Hung, RJ Hayostek - Radiologic clinics of North …, 1993 - Elsevier
Optimal bone scintigraphy is obtained by using a current generation gamma camera with a
high-resolution collimator, minimizing the patient-to-collimator distance, using scatter …

Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.

…, ML Brown, MK O'Connor, JC Hung, RJ Hayostek… - Radiology, 1993 - pubs.rsna.org
The purpose of this study was to evaluate the usefulness of a radiolabeled analog of
somatostatin (iodine-123 octreotide) in the detection and localization of known carcinoid and islet …

[PDF][PDF] Dosimetry and biodistribution of an iodine-123-labeled somatostatin analog in patients with neuroendocrine tumors

…, RJ Hayostek, DS Cho, RJ Vetter - Journal of Nuclear …, 1992 - Soc Nuclear Med
RESULTS Labeling Efficiency In the first 15 patients, 33.7% ±12.4% was recovered as â€
23I-octreotidein the 96% ethanol solution. Hence, initial activities of 60 mCi 1231were …

Radiosensitization of human tumor cells with levamisole

CJ Hayostek, TM Koval - Cancer research, 1992 - AACR
Levamisole in combination with radiation and chemotherapeutic agents is being studied in
clinical trials. The mechanism of interaction of levamisole with these modalities is unknown. …

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for …

…, A Yuen, R Nichols, S Yalavarthi, C Hayostek… - International Journal of …, 2013 - Elsevier
PURPOSE: To assess the efficacy of 2 different approaches to neoadjuvant chemoradiation
for distal rectal cancers. METHODS AND MATERIALS: One hundred six patients with T3/T4 …

[PDF][PDF] Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012

…, A Yuen, C Nichols, R Shane, C Hayostek… - Journal of Clinical …, 2006 - researchgate.net
… Mohammed Mohiuddin, Kathryn Winter, Edith Mitchell, Nader Hanna, Albert Yuen, Charles
Nichols, Robert Shane, Cherie Hayostek, and Christopher Willett … Douglas HO, Moertel CG …

[HTML][HTML] 5-year updated results of RTOG-0012 randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer

…, R Nichols, S Yalavarthi, C Hayostek… - … journal of radiation …, 2013 - ncbi.nlm.nih.gov
Purpose To assess the efficacy of two different approaches to neoadjuvant chemo-radiation
for distal rectal cancers. Materials and Methods 106 patients with T3/T4 distal rectal cancers …

2092: 3-Year Results of RTOG-0012 Randomized Phase II Study of Neoadjuvant Combined Modality Chemoradiation for Distal Rectal Cancer

…, A Yuen, C Nichols, RE Share, C Hayostek… - International Journal of …, 2006 - redjournal.org
Results All eligible patients that began protocol treatment are included in this analysis
including patients who had disease progression or died before surgery. 106 patients were …

[CITATION][C] O¶ connor, MK; Hung, JC; Hayostek, RJ; Reubi, JC and Lamberts, SW J.(1993), Evaluation of a Radiolabeled Somatostatin Analog (I 123 Octreotide) in …

LK Kvols, ML Brown - Radiology